The results of the experiment conducted on animals
by combining ACPs with drugs known to have excellent protective effects
on neurons confirmed that the ACPs could be delivered to the inside
of brain cells and cell nuclei by passing through the BBB.

• 

  Old man’s diseasesAdvances in medicine are allowing humans to live longer and have healthier bodies. On the other hand, brain diseases, such as dementia, Alzheimer's disease, Parkinson's disease, etc., have not yet been resolved. And, those diseases not only cause a lot of pain to patients and their families, but also take away the happiness of a family, illustrating an urgent need for the relevant drugs.

• Limitations in passing the BBB
  (blood-brain barrier)Many medicinal substances that have been confirmed to be effective in treating dementia through numerous studies, but the limitations of these medicinal substances in passing through BBB (blood-brain barrier) is a problem that modern medicine has not yet overcome. The BBB is one of the most powerful protective barriers created to biologically protect the human body and BBB penetration is the biggest obstacle to the development of drugs that can treat dementia by acting directly on the brain.

  
• 

  The drug that reaches brain cellsAs a results of in vivo experiments by conjugating ACP (Advanced Cell-Penetrating Peptide) to a drug for brain diseases, it was confirmed that it crosses the BBB (blood-brain barrier) and is delivered into brain cells and cell nuclei due to its excellent permeability. Accordingly, it is expected that the ACP can also be used in delivering the drug for brain diseases.